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Background
Breastfeeding is the gold standard of infant feeding,
however not all infants with cow’s milk protein allergy
(CMPA) tolerate human milk. In these cases, it seems
recommended the use of extensively hydrolyzed formula
(eHF). Preliminary analyses such as antigenicity and pro-
tein quality evaluation are needed to ensure that new
f o r m u l aw i l lb en u t r i t i o n a l l ysuitable, tolerated and safe
for infants with CMPA. The aim of this study was to
determine the protein quality of a whey hydrolysate
(WH) and casein hydrolysate (CH).
Methods
The Thomas-Mitchell method modified was used. Male
Wistar rats weighing about 50 g were housed in meta-
bolic cages and distributed in three groups fed with
diets only differ in protein source. Group 1 fed with
WH, group 2 fed with CH and group 3 fed with casein
+5% DL-methionine reference diet. Acclimatization of
five days followed of ten days with experimental diet. In
the last seven days we controlled daily intakes and col-
lected faeces and urine. For estimation of the protein
quality, true digestibility, net protein utilization (NPU),
biological value (BV) and protein efficiency ratio (PER),
were used. Nitrogen content was measured by means of
Kjeldahl method in diet, faeces and urine.
Results
WH and CH showed similar NPU (67,18%, 69,55%), BV
(72,99%, 75,26%) and PER (3,62, 3,69)). NPU, BV and
PER in control diet were (81,01%, 85,64% and 4,14).Both
hydrolysates complied with the requirements of PER
higher than 2.5 and BV higher than 70, considered as
adequate sources of amino nitrogen for human nutrition.
Conclusions
WH and CH are good protein sources to be used in the
design of a new eHF for the nutritional treatment of
infants with CMPA.
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